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CI, 3.43–28.30; P <0.001), major vascular compli‑
cation (OR, 12.40; 95% CI, 7.37–20.83; P <0.001), 
and severe anemia (OR, 3.47; 95% CI, 1.95–6.18; 
P <0.001). All of these predictors were associated 
with an increased risk of transfusion of at least 4 
RBC units.4 Unquestionably, there are other fac‑
tors that predict transfusion, such as lower body 
mass index, renal dysfunction, and antiplate‑
let and anticoagulant regimens. Several mecha‑
nisms have been proposed to explain the associ‑
ation of blood transfusion with worse outcomes. 
These include the impairment of oxygen delivery 
due to an increased oxygen affinity and decrease 
in deformability of stored RBCs, prothrombot‑
ic effects through an increased release of proco‑
agulants, and transfusion ‑related modulation of 
the immune system through alterations in cyto‑
kine levels.8 In addition, whether pretreatment 
of anemia (eg, iron substitution, erythropoietin) 
prior to TAVI improves the outcome remains to 
be determined, because anemia may just act as 
an indicator of frailty in these patients. Still, one 
could anticipate that the mitigation of anemia 
could result in a reduction in transfusion rates.9
In this issue of the Polish Archives of Internal 
Medicine, Czerwińska ‑Jelonkiewicz et al10 focused 
on different aspects of blood transfusion in pa‑
tients who underwent TAVI. The authors investi‑
gated the association between RBC storage time 
and the short‑ and long ‑term outcomes in this 
population of patients. In this retrospective, ob‑
servational study, 101 patients (56.7%) required 
blood transfusion during or after TAVI. Given 
that the mean number of transfused RBC units 
was 2 and the mean hemoglobin concentration 
prior to transfusion was 9.6 g/dl, patients were 
managed with a liberal rather than restrictive ap‑
proach to RBC transfusion. One could only spec‑
ulate whether the treatment of preexisting ane‑
mia prior to TAVI could have resulted in a fewer 
Transcatheter aortic valve implantation (TAVI) 
has become a viable therapeutic modality for in‑
operable or high‑surgical‑risk patients with se‑
vere aortic stenosis, who are not deemed suit‑
able for surgical aortic valve replacement. Bleed‑
ing and vascular access site complications range 
from 26% to 77% and 9.5% to 51.6%, respective‑
ly, and have been well documented to be associat‑
ed with worse outcomes.1 Aortic stenosis by itself 
could lead to hemolysis, which in turn may con‑
tribute to anemia. Bleeding events often require 
packed red blood cell (RBC) transfusion. Howev‑
er, the clinical decision regarding the necessity 
of RBC transfusion is challenging. Studies have 
shown that baseline anemia is the strongest pre‑
dictor of the need for RBC transfusion following 
both TAVI and aortic valve replacement.2,3 Not‑
withstanding, everyday clinical practice indicates 
that RBC transfusions are being administered in 
the absence of overt major bleeding or hemody‑
namic instability. More importantly, we must be 
aware that not every major bleeding results in 
a significant hemoglobin drop and thus may not 
require RBC transfusion.
Increased mortality, stroke, and acute kid‑
ney injury rates have been reported in patients 
who received RBC transfusions following TAVI.4 
The adverse effects of bleeding, anemia, and blood 
transfusion on short‑ and long ‑term outcomes 
are not just specific for TAVI. In addition, blood 
transfusion has been linked to worse prognosis 
following acute coronary syndromes,5 percuta‑
neous coronary intervention,6 and cardiac sur‑
gery.7 Tchetche et al4 identified independent pre‑
dictors of RBC transfusion following TAVI. These 
included female sex (odds ratio [OR], 2.11; 95% CI, 
1.32–3.37; P = 0.002), previous cerebrovascular 
accident (OR, 1.95; 95% CI, 1.13–3.38; P = 0.016), 
peripheral vascular disease (OR, 1.94; 95% CI, 
1.18–3.20; P = 0.01), major stroke (OR, 9.85; 95% 
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the risks of systemic inflammatory response, in‑
fectious risk associated with immunomodulation, 
and of organ failure.18 These mechanisms could 
play a central role in everyday clinical practice, as 
most patients receive only buffy ‑coat ‑depleted 
RBCs, which contain more leukocytes than leu‑
kodepleted RBCs. Finally, the oldest erythrocytes 
in each RBC unit are sensitive to prolonged stor‑
age; thus, they may contribute to adverse effects 
of even fresh RBCs due to microparticle forma‑
tion, release of hemoglobin and other intracellu‑
lar components, and iron overload.19,20 A recent 
meta ‑analysis and systematic review has indicat‑
ed that the current evidence provides moderate 
certainty that use of fresher RBCs does not in‑
fluence mortality, and low certainty that it does 
not influence adverse events but could possibly 
increase infection rates.21 In addition, handling of 
the blood products greatly influences the quality 
of both the shorter‑ and the longer ‑stored RBC 
units. Once issued by the blood bank, the trans‑
fusion of RBC units should be commenced with‑
in 30 minutes of removal from the optimal stor‑
age conditions.
The transfusion community seems to be losing 
interest in fierce “new blood – old blood” debates, 
and instead agrees on the need to welcome the op‑
portunity provided by omics/laboratory studies to 
further improve blood storage quality. To estab‑
lish the effect of the storage time of blood prod‑
ucts on clinical outcome, a well ‑controlled clinical 
trial, particularly with a strictly followed storage, 
rewarming, and transfusion protocol, is needed.
In conclusion, although literature data present 
a worrisome picture of potential storage compli‑
cations, current findings are too inconsistent to 
drive changes in clinical practice. Perhaps the re‑
sults of ongoing RCTs will shed new light and con‑
tribute to recommendations on RBC storage time 
in patients undergoing cardiac procedures and in 
those critically ill.
REFERENCES
1 Genereux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes af‑
ter transcatheter aortic valve replacement using valve academic research 
consortium definitions: a weighted meta ‑analysis of 3,519 patients from 16 
studies. J Am Coll Cardiol. 2012; 59: 2317‑2326.
2 Nuis RJ, Sinning JM, Rodes ‑Cabau J, et al. Prevalence, factors associ‑
ated with, and prognostic effects of preoperative anemia on short‑ and long‑
‑term mortality in patients undergoing transcatheter aortic valve implanta‑
tion. Circ Cardiovasc Interv. 2013; 6: 625‑634.
3 Van Mieghem NM, Nuis RJ, Tzikas A, et al. Prevalence and prognostic 
implications of baseline anaemia in patients undergoing transcatheter aortic 
valve implantation. EuroIntervention. 2011; 7: 184‑191.
4 Tchetche D, Van der Boon RM, Dumonteil N, et al. Adverse impact of 
bleeding and transfusion on the outcome post ‑transcatheter aortic valve im‑
plantation: insights from the Pooled ‑RotterdAm ‑Milano ‑Toulouse In Collabo‑
ration Plus (PRAGMATIC Plus) initiative. Am Heart J. 2012; 164: 402‑409.
5 Chatterjee S, Wetterslev J, Sharma A, et al. Association of blood trans‑
fusion with increased mortality in myocardial infarction: a meta ‑analysis and 
diversity ‑adjusted study sequential analysis. JAMA Intern Med. 2013; 173: 
132‑139.
6 Sherwood MW, Wang Y, Curtis JP, et al. Patterns and outcomes of red 
blood cell transfusion in patients undergoing percutaneous coronary inter‑
vention. JAMA. 2014; 311: 836‑843.
7 Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoper‑
ative morbidity, and cost after red blood cell transfusion in patients having 
cardiac surgery. Circulation. 2007; 116: 2544‑2552.
blood transfusions. The authors concluded that 
shorter ‑stored RBC units and a great discrepancy 
in RBC age in multi ‑transfused elderly patients 
after TAVI might have a deleterious effect on life 
expectancy. However, the authors did not offer 
any definition of shorter storage. The mean stor‑
age time was 17 days for those who died within 30 
days and 19 days for those who survived, while it 
was 19 days for those who died within 12 months 
and 25 days for those who survived. Meanwhile, 
most authors use the 7 ‑day cut ‑off for shorter‑
‑stored RBC units. Therefore, actually the patients 
who died received RBC units that were stored for 
a relatively longer time. In a multivariable analy‑
sis, only the number of RBC units transfused re‑
mained the independent predictor of long ‑term 
mortality. The storage time did not reach statis‑
tical significance. The minor association or lack 
thereof is further supported by only a weak C ‑sta‑
tistic (area under the receiver characteristic oper‑
ating curve of 0.59 for the number of RBC units 
and of 0.63 for the storage time of RBC units).
The storage time has recently attracted con‑
siderable attention. Current regulations permit 
the storage of RBC units for up to 42 days. How‑
ever, over time, several biochemical changes in 
RBCs may occur, both in RBCs themselves and 
in the preservative medium.11 Thus, prolonged 
storage may render erythrocytes ineffective as 
oxygen carriers, which leads to the accumulation 
of substances that exert adverse biologic effects.
There are several methods of producing RBC 
units. Different production methods may account 
for the various effects on the degree and magni‑
tude of RBC lesions related to the storage period. 
The occurrence of RBC storage lesion has raised 
safety concerns with transfusions, particularly 
when longer ‑stored RBC units are used. A system‑
atic review of 18 observational studies and 3 ran‑
domized controlled trials (RCTs) involving more 
than 400 000 patients suggested that the trans‑
fusion of longer ‑stored RBC units was potential‑
ly associated with a significantly increased risk 
of death.12 However, this effect was reported in 
observational studies. The results of most RCTs 
did not detect clinically relevant consequences of 
longer ‑stored RBC transfusion.13‑15 Recent stud‑
ies seem to be more balanced, indicating no rele‑
vant relationship between prolonged storage and 
worse outcomes. Interestingly, some studies have 
even suggested worse outcomes with fresh RBC 
transfusion.14,16
There is no clear explanation why transfusions 
of shorter ‑stored RBC units might be associated 
with increased mortality. One of the few chang‑
es in RBC units that might have a positive clini‑
cal effect is the gradual demise of leukocytes. Up 
to 106 of leukocytes are allowed per unit even in 
the leukodepleted RBC products. Transfusion of 
fresher RBC units could result in increased mi‑
crochimerism. Furthermore, microchimerism 
has also been observed in a substantial fraction 
of leukodepleted RBC recipients.17 An excessive 
amount of donor white blood cells increases 
EDITORIAL Does the issue of stored blood get old: is all blood equal? 475
8 Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr. Bleeding, blood 
transfusion, and increased mortality after percutaneous coronary interven‑
tion: implications for contemporary practice. J Am Coll Cardiol. 2009; 53: 
2019‑2027.
9 Seiffert M, Conradi L, Terstesse AC, et al. Blood transfusion is associ‑
ated with impaired outcome after transcatheter aortic valve implantation. 
Catheter Cardiovasc Interv. 2015; 85: 460‑467.
10 Czerwinska‑Jelonkiewicz K, Letowska M, Witkowski A, et al. Signifi‑
cance of the age of transfused blood for prognosis after transcatheter aortic 
valve implantation. Pol Arch Intern Med. 2017; 127: 490‑497.
11 Tinmouth A, Fergusson D, Yee IC, Hebert PC. Clinical consequences of 
red cell storage in the critically ill. Transfusion. 2006; 46: 2014‑2027.
12 Wang D, Sun J, Solomon SB, et al. Transfusion of older stored blood 
and risk of death: a meta ‑analysis. Transfusion. 2012; 52: 1184‑1195.
13 Lacroix J, Hebert PC, Fergusson DA, et al. Age of transfused blood in 
critically ill adults. N Engl J Med. 2015; 372: 1410‑1418.
14 Heddle NM, Eikelboom J, Liu Y, et al. Exploratory studies on the age of 
transfused blood and in ‑hospital mortality in patients with cardiovascular di‑
agnoses. Transfusion. 2015; 55: 364‑372.
15 Steiner ME, Ness PM, Assmann SF, et al. Effects of red ‑cell storage 
duration on patients undergoing cardiac surgery. N Engl J Med. 2015; 372: 
1419‑1429.
16 Middelburg RA, van de Watering LM, Briet E, van der Bom JG. Stor‑
age time of red blood cells and mortality of transfusion recipients. Transfus 
Med Rev. 2013; 27: 36‑43.
17 Utter GH, Nathens AB, Lee TH, et al. Leukoreduction of blood transfu‑
sions does not diminish transfusion ‑associated microchimerism in trauma 
patients. Transfusion. 2006; 46: 1863‑1869.
18 Sharma RR, Marwaha N. Leukoreduced blood components: Advan‑
tages and strategies for its implementation in developing countries. Asian 
J Transfus Sci. 2010; 4: 3‑8.
19 Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulat‑
ing, and prothrombotic properties of anemia and red blood cell transfusions. 
J Thromb Thrombolysis. 2006; 21: 167‑174.
20 Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte age‑
ing in vivo and in vitro: structural aspects and implications for transfusion. 
Transfus Med. 2008; 18: 335‑347.
21 Alexander PE, Barty R, Fei Y, et al. Transfusion of fresher vs older red 
blood cells in hospitalized patients: a systematic review and meta ‑analysis. 
Blood. 2016; 127: 400‑410.
